Cited by 110Estrogen and related hormone effectsMale Breast Health StudiesEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 124 of the 129 references it cites were found in a registry or an index.

The estrogenic and antiestrogenic activities of androgens in female target tissues.

Rochefort, Henri, Garcia, Marcel·1983·Pharmacology & Therapeutics

DOI 10.1016/0163-7258(83)90013-x

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0163-7258(83)90013-x

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens
Ziel, H. K., & Finkle, W. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512042932303 · Cited by 1,007
Association of Exogenous Estrogen and Endometrial Carcinoma
SMITH, D. C. C., Prentice, R. L., Thompson, D. J., & HERRMANN, W. L. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512042932302 · Cited by 960
The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
Lippman, M. E., Bolan, G., & Huff, K. K. (1976) · PubMed · Cited by 808
Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.
Horwitz, K. B., & McGuire, W. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38062-6 · Cited by 798
Characterization and measurement of dehydroepiandrosterone sulfate in rat brain
Corpéchot, C., Robel, P., Axelson, M., Sjövall, J., & Baulieu, E. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4704 · Cited by 656
Estrogen Receptors in Human Breast Cancer
Powles, T. J. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.5.467-d · Cited by 614
Handbook of Physiology. Section- 2
HAMILTON, W. F., & Cloth, P. D. (1967) · Anesthesiology · doi:10.1097/00000542-196701000-00101 · Cited by 533
“Pleiotypic Response”
Hershko, A., Mamont, P. S., Shields, R. L., & Tomkins, G. M. (1971) · Nature New Biology · doi:10.1038/newbio232206a0 · Cited by 516
A secreted glycoprotein induced by estrogen in human breast cancer cell lines
Westley, B. (1980) · Cell · doi:10.1016/0092-8674(80)90621-2 · Cited by 477
Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle
ABRAHAM, G. E. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-340 · Cited by 436

Show all 129 references

Research works printed but not linked: 8

Baulieu, 1971, Rec. Prog. Horm. Res., 27, 351
Boris, 1967, Uterotrophic activities of some androgenic steroids in the immature mouse, Eur. J. Steroids, 2, 539
Costlow, 1976, Prolactin receptors and androgen-induced regression of 7,12 dimethylbenzanthracène-induced mammary carcinoma, Cancer Res., 36, 3324
Grattarola, 1977, The hormonal background of breast non cancerous diseases, Senologia, 2, 19
Jensen, 1962, Basic Guides to the mechanism of estrogen action, Rec. Prog. Horm. Res., 18, 387
Loeser, 1939, Male hormone in the treatment of cancer of the breast, Acta univ. inr. contr. canc., 4, 375
Minesita, 1965, An androgen dependant mouse mammary tumour, Cancer Res., 25, 1168
Ulrich, 1939, La testostérone (hormone mâle) et son rôle possible dans le traitement de certains cancers du sein, Acta. un. int. cancer, 4, 377

Sorted by citations

Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
The role of estradiol in male reproductive function
Ramasamy, R., Schulster, M., & Bernie, A. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.173932 · Cited by 411
Gynecomastia
Desforges, J. F., & Braunstein, G. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280708 · Cited by 395
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
Platet, N., Cathiard, A. M., Gleizes, M., & Garcia, M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.02.001 · Cited by 368
Self-citation
Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment
Gooren, L. J., van Trotsenburg, M. A. A., Giltay, E. J., & van Diest, P. J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12319 · Cited by 246
Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin, R., & Labrie, F. (1986) · PubMed · Cited by 200
EAA clinical practice guidelines—gynecomastia evaluation and management
Kanakis, G., Nordkap, L., Bang, A. K., Calogero, A. E., Bártfai, G., Corona, G., Forti, G., Toppari, J., Goulis, D. G., & Jørgensen, N. (2019) · Andrology · doi:10.1111/andr.12636 · Cited by 205
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Poulin, R., Baker, D., & Labrie, F. (1988) · Breast Cancer Research and Treatment · doi:10.1007/bf01805942 · Cited by 172
(S)-(+)-4-[7-(2,2-Dimethyl-1-oxopro- poxy)-4-methyl-2-[4-[2-(1-piperidinyl)- ethoxy]phenyl]-2H-1-benzopyran-3-yl]- phenyl 2,2-Dimethylpropanoate (EM-800): A Highly Potent, Specific, and Orally Active Nonsteroidal Antiestrogen
Gauthier, S., Caron, B., Cloutier, J., Dory, Y. L., Favre, A., Larouche, D., Mailhot, J., Ouellet, C., Schwerdtfeger, A., Leblanc, G., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970095o · Cited by 156
RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
BARDON, S., VIGKPN, F., CHALBOS, D., & ROCHEFORT, H. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-692 · Cited by 143
Self-citation
MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone
Russell, N., & Grossmann, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-1000 · Cited by 145
Preeclampsia and Breast Cancer Risk
Innes, K. E., & Byers, T. (1999) · Epidemiology · doi:10.1097/00001648-199911000-00013 · Cited by 135
Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.
POULIN, R., SIMARD, J., LABRIE, C., PETITCLERC, L., DUMONT, M., LAGACÉ, L., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-125-1-392 · Cited by 115
Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines
Ortmann, J., Prifti, S., Bohlmann, M. K., Rehberger-Schneider, S., Strowitzki, T., & Rabe, T. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.2.113.120 · Cited by 102
Estradiol Down-Regulates the Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptor Gene and Induces Cathepsin-D in Breast Cancer Cells: A Receptor Saturation Mechanism to Increase the Secretion of Lysosomal Proenzymes
Mathieu, M. N., Vignon, F., Capony, F., & Rochefort, H. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-6-815 · Cited by 89
Self-citation
Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia
Ersöz, H. Ö., Önde, M. E., Terekeci, H., Kurtoglu, S., & Tor, H. (2002) · International Journal of Andrology · doi:10.1046/j.1365-2605.2002.00374.x · Cited by 85
Power-Assisted Liposuction and the Pull-Through Technique for the Treatment of Gynecomastia
Lista, F. R., & Ahmad, J. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000299907.04502.2f · Cited by 85
Regulation of Mouse Liver Flavin-Containing Monooxygenases 1 and 3 by Sex Steroids
Falls, J. G., Ryu, D., Cao, Y., Levi, P. E., & Hodgson, E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9965 · Cited by 83
Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals
Slagter, M. H., Gooren, L. J., Scorilas, A., Petraki, C. D., & Diamandis, E. P. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a6928.2006 · Cited by 84
Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1
Galtier, F., Capony, F., Maudelondé, T., & Rochefort, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.6.1497 · Cited by 82
Self-citation
Relationship of Adolescent Gynecomastia with Varicocele and Somatometric Parameters: A Cross-Sectional Study in 6200 Healthy Boys
Kumanov, P., Deepinder, F., Robeva, R. N., Tomova, A., Li, J., & Agarwal, A. K. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.03.010 · Cited by 80
Management of gynaecomastia: an update
Gikas, P. D., & Mokbel, K. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01095.x · Cited by 79
Induction of 3 -Hydroxysteroid Dehydrogenase/ 5- 4 Isomerase Type 1 Gene Transcription in Human Breast Cancer Cell Lines and in Normal Mammary Epithelial Cells by Interleukin-4 and Interleukin-13
Gingras, S., Moriggl, R., Groner, B., & Simard, J. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0221 · Cited by 77
Novel compounds inhibit estrogen formation and action.
Labrie, C., Martel, C., Dufour, J. M., Lévesque, C., Mérand, Y., & Labrie, F. (1992) · PubMed · Cited by 73
Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
Salerno, M., Cascio, O., Bertozzi, G., Sessa, F., Messina, A., Monda, V., Cipolloni, L., Biondi, A., Daniele, A., & Pomara, C. (2018) · Oncotarget · doi:10.18632/oncotarget.24767 · Cited by 71
Intratissular androgens in benign prostatic hyperplasia and prostatic cancer
Voigt, K., & BARTSCH, W. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90304-3 · Cited by 71
Androstenedione and androst-5-ene-3β,17β-diol stimulate DMBA-induced rat mammary tumors — role of aromatase
Dauvois, S., & Labrie, F. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806551 · Cited by 68
Enzymes of Androgen Formation and Degradation in the Human Prostate
BARTSCH, W., Klein, H., Schiemann, U., Bauer, H. W., & Voigt, K. D. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34282.x · Cited by 67
Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
Chalbos, D., Haagensen, D. E., Parish, T., & Rochefort, H. (1987) · PubMed · Cited by 66
Self-citation
Does Early Physical Maturity Influence Breast Cancer Risk?
Stoll, B. A., VATTEN, L. J., & Kvinnsland, S. (1994) · Acta Oncologica · doi:10.3109/02841869409098400 · Cited by 65
Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in T 47D breast cancer cells
Escaleira, M. T. F., Sonohara, S., & Brentani, M. M. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90340-3 · Cited by 62
Surgical Management of Gynecomastia: Subcutaneous Mastectomy and Liposuction
Kim, D. H., Byun, I. H., Lee, W. J., Rah, D. K., Kim, J. Y., & Lee, D. W. (2016) · Aesthetic Plastic Surgery · doi:10.1007/s00266-016-0705-y · Cited by 53
Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β,17β-diol in human mammary cancer cells
Hackenberg, R., Turgetto, I., Filmer, A., & Schulz, K.-D. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90187-2 · Cited by 52
A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: Hormonal control of β-adrenergic receptors and correlation with tumor growth
Marchetti, B., Spinola, P. G., Pelletier, G., & Labrie, F. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90102-b · Cited by 50
Breast cancer: the obesity connection
Stoll, B. A. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.157 · Cited by 49
A Novel A10E Homozygous Mutation in the HSD3B2 Gene Causing Severe Salt-Wasting 3 -Hydroxysteroid Dehydrogenase Deficiency in 46,XX and 46,XY French-Canadians: Evaluation of Gonadal Function after Puberty
Alos, N., Moisan, A. M., Ward, L. M., Desrochers, M., Legault, L., LEBOEUF, G., Vliet, G. V., & Simard, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6581 · Cited by 50
Sex hormone-induced mammary carcinogenesis in female Noble rats: the role of androgens
Xie, B. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1597 · Cited by 48
Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.
Dauvois, S., Li, S., Martel, C., & Labrie, F. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806301 · Cited by 47
Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800
Sourla, A., Luo, S., Labrie, C., Bélanger, A., & Labrie, F. (1997) · Endocrinology · doi:10.1210/endo.138.12.5560 · Cited by 46
Combined Effects of Dehydroepiandrosterone and EM-800 on Bone Mass, Serum Lipids, and the Development of Dimethylbenz(A)Anthracene-Induced Mammary Carcinoma in the Rat
Luo, S., Sourla, A., Labrie, C., Bélanger, A., & Labrie, F. (1997) · Endocrinology · doi:10.1210/endo.138.10.5429 · Cited by 44
Adrenal androgens and human breast cancer: A new appraisal
Adams, J. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006050720900 · Cited by 42
Crucial role of cytokines in sex steroid formation in normal and tumoral tissues
Simard, J., & Gingras, S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00387-7 · Cited by 40
Quality of life as an outcome variable in the management of cancer pain
FERRELL, B. R., Wisdom, C., & Wenzl, C. (1989) · Cancer · doi:10.1002/1097-0142(19890601)63:11 · Cited by 219
Selective conversion by microglia of dehydroepiandrosterone to 5-androstenediol—A steroid with inherent estrogenic properties
Jellinck, P. H., Kaufmann, M., Gottfried‐Blackmore, A., McEwen, B. S., Jones, G., & Bulloch, K. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.04.004 · Cited by 38
Neurosteroids: Synthesis and Functions in the Central and Peripheral Nervous Systems
Schumacher, M., & Baulieu, É.-É. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514757.ch6 · Cited by 36
Induction of high incidence of mammary tumour in female Noble rats with a combination of 17-oestradiol and testosterone
Xie, B. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1069 · Cited by 35
Estrogen Down-Regulation of Androgen Receptors in Cultured Human Mammary Cancer Cells (MCF-7)*
Stover, E. P., Krishnan, A. V., & Feldman, D. (1987) · Endocrinology · doi:10.1210/endo-120-6-2597 · Cited by 35
The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines
Aspinall, S. R., Stamp, S., Davison, A., Shenton, B. K., & Lennard, T. W. J. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.10.011 · Cited by 34
Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line
Thomas, M., & Monet, J.-D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.865 · Cited by 34
5-En-androstene-3 β,17 β-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol
Boccuzzi, G., Brignardello, E., Monaco, M. D., Gatto, V., Leonardi, L., Pizzini, A., & Gallo, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.444 · Cited by 34
Effect of Twenty-Four-Week Treatment with the Antiestrogen EM-800 on Estrogen-Sensitive Parameters in Intact and Ovariectomized Mice
Luo, S., Sourla, A., Labrie, C., Gauthier, S., Mérand, Y., Bélanger, A., & Labrie, F. (1998) · Endocrinology · doi:10.1210/endo.139.5.5994 · Cited by 33
Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia
Brochu, M., & Bélanger, A. (1987) · The Prostate · doi:10.1002/pros.2990110105 · Cited by 31
Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes
Fernández‐Pérez, L., Chirino, R., Boada, L. D., Navarro, D., Cabrera, N., del Río, I., & Díaz-Chico, B. N. (1994) · Endocrinology · doi:10.1210/en.134.3.1401 · Cited by 31
Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach
Brentani, M. M., Franco, E. L., Oshima, C. T. F., & Pacheco, M. M. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380504 · Cited by 30
Do antiestrogens and antiprogestins act as hormone antagonists or receptor-targeted drugs in breast cancer?
Rochefort, H. (1987) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(87)90180-5 · Cited by 29
Self-citation
Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation
Sirianni, R., Capparelli, C., Chimento, A., Panza, S., Catalano, S., Lanzino, M., Pezzi, V., & Andò, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.002 · Cited by 25
Nandrolone and stanozolol induce leydig cell tumor proliferation through an estrogen‐dependent mechanism involving IGF‐I system
Chimento, A., Sirianni, R., Zolea, F., Luca, A. D., Lanzino, M., Catalano, S., Andò, S., & Pezzi, V. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22936 · Cited by 25
Marked Increase in Incident Gynecomastia: A 20-Year National Registry Study, 1998 to 2017
Koch, T., Bräuner, E. V., Busch, A. S., Hickey, M., & Juul, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa440 · Cited by 25
Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor.
Casey, R. W., & Wilson, J. D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111654 · Cited by 25
Estrogenic and progestational activity of 7α-methyl-19-nortestosterone, a synthetic androgen
Beri, R., Kumar, N., Savage, T., Benalcazar, L., & Sundaram, K. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00114-9 · Cited by 22
Metabolism of androgens in human benign prostatic hyperplasia: Aromatase and its inhibition
BARTSCH, W., Klein, H., Stürenburg, H.-J., & Voigt, K. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90354-2 · Cited by 22
C19 steroids estrogenic activity in human breast cancer cell lines: importance of dehydroepiandrosterone sulfate at physiological plasma concentration
Bail, J.-C. L., Marre-Fournier, F., Nicolas, J., & Habrioux, G. (1998) · Steroids · doi:10.1016/s0039-128x(98)00078-6 · Cited by 22
Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs
Simard, J., & Labrie, F. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90005-7 · Cited by 22
Androgens and human benign prostatic hyperplasia (BPH)
Krieg, M., & Tunn, S. (1990) · Springer eBooks · doi:10.1007/978-3-662-00814-0_12 · Cited by 22
Gynecomastia - a difficult diagnostic problem.
Derkacz, M., Chmiel-Perzyńska, I., & Nowakowski, A. M. (2011) · PubMed · Cited by 19
A somatostatin analogue decreases embryonic loss following superovulation in rats by normalizing insulin-like growth factor-I action in the uterus
Katagiri, S., Moon, Y. S., & Yuen, B. H. (1997) · Human Reproduction · doi:10.1093/humrep/12.4.671 · Cited by 19
17β-Hydroxysteroid dehydrogenase in the human prostate. Properties and distribution between epithelium and stroma in benign hyperplastic tissue
BARTSCH, W., Greeve, J. C., & Voigt, K. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90121-x · Cited by 19
Concentrations of 3β‐hydroxy androgens in epithelium and stroma of benign hyperplastic and normal human prostate
BARTSCH, W., Kozák, I., Gorenflos, P., Becker, H., & Voigt, K. (1986) · The Prostate · doi:10.1002/pros.2990080103 · Cited by 18
The Satisfaction Rate among Patients and Surgeons after Periareolar Surgical Approach to Gynecomastia along with Liposuction.
Taheri, A. R., Farahvash, M. R., Fathi, H. R., Ghanbarzadeh, K., & Faridniya, B. (2016) · PubMed Central · Cited by 17
Formation and turnover of long-chain fatty acid esters of 5-androstene-3β,17β -diol in estrogen receptor positive and negative human mammary cancer cell lines in culture
Adams, J. B., Martyn, P., Smith, D. L., & Nott, S. E. (1988) · Steroids · doi:10.1016/0039-128x(88)90017-7 · Cited by 16
Wide spectrum of steroids serving as substrates for the formation of lipoidal derivatives in ZR-75-1 human breast cancer cells
Poulin, R., Poirier, D., Thériault, C., Couture, J., Bélanger, A., & Labrie, F. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90280-6 · Cited by 16
Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines
Robert Kiss, A., de Launoit, Y., Wouters, W., Deslypère, J. P., Lescrainier, J., Paridaens, R., Vokaer, A., Decoster, R., & Pasteels, J. L. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90129-6 · Cited by 15
Sex hormone-induced mammary carcinogenesis in the female Noble rats: Expression of Bcl-2 and Bax in hormonal mammary carcinogenesis
Xie, B., Tsao, S. W., & Wong, Y. C. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006400732154 · Cited by 14
Influence of culture media on the morphological differentiation of the PC‐3 and DUI45 prostatic neoplastic cell lines
Camby, I., Dedecker, R., Danguy, A. J., Pasteels, J., Robert Kiss, A., Pétein, M., Etiévant, C., & van Velthoven, R. (1994) · The Prostate · doi:10.1002/pros.2990240404 · Cited by 13
Sex hormone-induced mammary carcinogenesis in female Noble rats: Expression of TGF-β1 and its receptors, TGF-α, and EGF-R in mammary carcinogenesis
Xie, B., Tsao, S. W., & Wong, Y. C. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006349532643 · Cited by 13
Estrogen-stimulated glucuronidation of dihydrotestosterone in MCF-7 human breast cancer cells
Roy, R., Dauvois, S., Labrie, F., & Bélanger, A. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90387-x · Cited by 12
Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease
Maudelondé, T., Lavaud, P., Salazar, G., Laffargue, F., & Rochefort, H. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01980939 · Cited by 12
Self-citation
Tissue Renin-Angiotensin Systems Aspects of Molecular Biology and Pharmacology
Metzger, R., Wagner, D., Takahashi, S., Suzuki, F., Lindpaintner, K., & Ganten, D. (1988) · Clinical and Experimental Hypertension · doi:10.1080/07300077.1988.11878913 · Cited by 11
Rapid occurrence of thelarche and menarche induced by hydrocortisone in a teenage girl with previously untreated congenital adrenal hyperplasia
Schwarz, H. P., Jocham, A., & Kuhnle, U. (1995) · European Journal of Pediatrics · doi:10.1007/bf02079062 · Cited by 9
In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminogluthetimide
de Launoit, Y., & Robert Kiss, A. (1989) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00397912 · Cited by 9
Serum adrenal androgens in women with primary operable breast cancer and their relationship with age and body mass index
Aspinall, S. R., Cook, D. B., Shenton, B. K., Griffiths, A. B., Griffith, C. D. M., Bliss, R., & Lennard, T. W. J. (2003) · The Breast · doi:10.1016/s0960-9776(02)00264-3 · Cited by 7
Potent Antagonism between Estrogens and Androgens on GCDFP‐15 Expression and Cell Growth in the ZR‐75‐1 Human Breast Cancer Cellsa
Labrie, F., Simard, J., Poulin, R., Hatton, A.-C., Labrie, C., Dauvois, S., Zhao, H., PETITCLERC, L., Couët, J., Dumont, M., et al. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17805.x · Cited by 7
Effect of acute ACTH administration on plasma steroid levels in the dog
Tremblay, Y., & Bèlanger, A. (1984) · Steroids · doi:10.1016/s0039-128x(84)80016-1 · Cited by 7
The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum
Esfahani, A., Kendall, C. W. C., Bashyam, B., Archer, M. C., & Jenkins, D. J. A. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9351-x · Cited by 6
Relationship between steroid levels in peripheral serum and uterine tissue during pseudopregnancy in rabbit
Dugré, F. J., Lambert, R. D., Bèlanger, A., & Fortier, M. A. (1989) · Theriogenology · doi:10.1016/0093-691x(89)90541-4 · Cited by 5
The Influence of 17-Oxo- and 17-Hydroxy-16,17-secoestratriene Derivatives on Estrogen Receptor
Jovanović-Šanta, S., Petrović, J., Sakač, M. N., Žakula, Z., Isenović, E. R., & Ribarac-Stepić, N. (2006) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20060532 · Cited by 4
Gynecomastia
Mancino, A. T., Young, Z. T., & Bland, K. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00007-6 · Cited by 4
RU 486: A Full Progestin Antagonist in Human Breast Cancer Cell Lines
Rochefort, H., & Chalbos, D. (1985) · Springer eBooks · doi:10.1007/978-1-4684-1242-0_28 · Cited by 4
Self-citation
Antiestrogenic Action of Dihydrotestosterone in Mouse Breast
Casey, R. W., & Wilson, J. D. (1984) · Cited by 4
Androgens, DHEA and breast cancer
Labrie, F., Poulin, R., Simard, J., Luu-The, V., Labrie, C., & Bélanger, A. (2005) · CRC Press eBooks · doi:10.1201/b14632-13 · Cited by 4
Management of gynecomastia in adolescence and adults: the clinical practice guidelines from the Italian Society of Andrology and Sexual Medicine (SIAMS)
Pozza, C., Selice, R., Barbonetti, A., Hasenmajer, V., Lotti, F., Menafra, D., Pasquali, D., Sansone, A., Isidori, A. M., & Rochira, V. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02915-2 · Cited by 3
Modification of Combined Vibrated Power Assisted Liposuction with Periareolar Gland Excision in management of Gynecomastia
Qaradaxi, K. A. (2018) · AL-Kindy College Medical Journal · doi:10.47723/kcmj.v14i1.10 · Cited by 2
Gynecomastia
Beenken, S. W., Page, D. L., & Bland, K. I. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5221-0.00007-3 · Cited by 2
Surgical management of gynecomastia: choice and outcome
Fayed, H. M. A., & Kholosy, H. (2018) · The Egyptian Journal of Surgery · doi:10.4103/ejs.ejs_111_17 · Cited by 1
Gynecomastia: pathogenesis and approaches to treatment
Eristavi, S. K., Rozhivanov, R. V., Романовна, Р. Е., Andreeva, E. N., Mel'nichenko, G. A., & Mokrysheva, N. G. (2025) · Bulletin of Reproductive Health · doi:10.14341/brh12752 · Cited by 1
Gynecomastia — a difficult diagnostic problem Ginekomastia — trudny problem diagnostyczny
Derkacz, M., Chmiel-Perzyńska, I., & Nowakowski, A. M. (2011) · Cited by 1
Evaluation of Serum Vitamin D Levels in Adolescents with Pubertal Gynecomastia
Kızılkan, M. P., Akgül, S., Akbıyık, F., Derman, O., & Kanbur, N. (2016) · Breast Care · doi:10.1159/000451074 · Cited by 1
Validated high-performance liquid chromatographic methods for quantitation of a novel nonsteroidal antiestrogen
Coquet, A., Boudreau, N., Mérand, Y., & Labrie, F. (1998) · Journal of Chromatography A · doi:10.1016/s0021-9673(98)00813-9 · Cited by 1
Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1α action in mouse mammary tumor cells
Hida, N., Poulin, R., Veilleux, R., & Labrie, F. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00120-x · Cited by 1

Authors: Rochefort, H., & Garcia, M.
Affiliations: Inserm (FR)
ORCID: Garcia, Marcel
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 1983-01
Volume: 23
Issue: 2
Pages: 193-216
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/0163-7258(83)90013-x
OpenAlex: W2023676722
Cited by: 107
References: 129
Citations by year: 2026: 2 · 2025: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 4 · 2013: 1 · 2012: 1
FWCI: 2.62
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Oncology › Male Breast Health Studies
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords: androgens, estrogenic activity, antiestrogenic activity, gynecomastia, male breast enlargement, breast histopathology
MeSH terms: Androgens, Animals, Breast Neoplasms, Cell Nucleus, Estrogen Antagonists, Estrogens, Female, Humans, Neoplasms, Receptors, Estrogen, Receptors, Progesterone, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The estrogenic and antiestrogenic activities of androgens in female target tissues.

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks